nafronyl has been researched along with Inflammation in 1 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waly, OM | 1 |
| El-Mahdy, NA | 1 |
| El-Shitany, NAE | 1 |
| Mohammedsaleh, ZM | 1 |
| El-Kadem, AH | 1 |
1 other study available for nafronyl and Inflammation
| Article | Year |
|---|---|
Protective role of naftidrofuryl against methotrexate-induced testicular damage via the amelioration of the p53/miRNA-29a/CDC42 apoptotic pathway, inflammation, and oxidative stress.
Topics: Animals; Antioxidants; Apoptosis; Inflammation; Male; Methotrexate; MicroRNAs; Nafronyl; Oxidative S | 2023 |